These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The nephropathy of sickle cell trait and sickle cell disease. Ataga KI; Saraf SL; Derebail VK Nat Rev Nephrol; 2022 Jun; 18(6):361-377. PubMed ID: 35190716 [TBL] [Abstract][Full Text] [Related]
5. [Spectrum of renal manifestations in sickle cell disease]. Cazenave M; Koehl B; Nochy D; Tharaux PL; Audard V Nephrol Ther; 2014 Feb; 10(1):10-6. PubMed ID: 24113202 [TBL] [Abstract][Full Text] [Related]
6. Emerging Therapies and Advances in Sickle Cell Disease with a Focus on Renal Manifestations. Obadina M; Wilson S; Derebail VK; Little J Kidney360; 2023 Jul; 4(7):997-1005. PubMed ID: 37254256 [TBL] [Abstract][Full Text] [Related]
7. Sickle Cell Disease and Kidney. Amarapurkar P; Roberts L; Navarrete J; El Rassi F Adv Chronic Kidney Dis; 2022 Mar; 29(2):141-148.e1. PubMed ID: 35817521 [TBL] [Abstract][Full Text] [Related]
8. Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients. Belisário AR; da Silva AA; Silva CV; de Souza LM; Wakabayashi EA; Araújo SA; Simoes-E-Silva AC Biomark Med; 2019 Aug; 13(11):967-987. PubMed ID: 31390894 [TBL] [Abstract][Full Text] [Related]
9. The glomerulopathy of sickle cell disease. Ataga KI; Derebail VK; Archer DR Am J Hematol; 2014 Sep; 89(9):907-14. PubMed ID: 24840607 [TBL] [Abstract][Full Text] [Related]
10. The kidney in sickle hemoglobinopathies . Airy M; Eknoyan G Clin Nephrol; 2017 Feb; 87 (2017)(2):55-68. PubMed ID: 27900941 [TBL] [Abstract][Full Text] [Related]
11. Urinary Transforming Growth Factor β-1 as a Marker of Renal Dysfunction in Sickle Cell Disease. Ghobrial EE; Abdel-Aziz HA; Kaddah AM; Mubarak NA Pediatr Neonatol; 2016 Jun; 57(3):174-80. PubMed ID: 26508723 [TBL] [Abstract][Full Text] [Related]
12. Sickle Cell Disease and CKD: An Update. Zahr RS; Saraf SL Am J Nephrol; 2024; 55(1):56-71. PubMed ID: 37899028 [TBL] [Abstract][Full Text] [Related]
13. Nephrin as a biomarker of sickle cell glomerulopathy in Malawi. Heimlich JB; Chipoka G; Elsherif L; David E; Ellis G; Kamthunzi P; Krysiak R; Mafunga P; Zhou Q; Cai J; Gopal S; Key NS; Ataga KI Pediatr Blood Cancer; 2018 Jun; 65(6):e26993. PubMed ID: 29411937 [TBL] [Abstract][Full Text] [Related]
14. Proteomic analyses of urinary exosomes identify novel potential biomarkers for early diagnosis of sickle cell nephropathy, a sex-based study. Packialakshmi B; Limerick E; Ackerman HC; Lin X; Nekhai S; Oliver JD; Stewart IJ; Knepper MA; Fitzhugh C; Zhou X Front Physiol; 2024; 15():1300667. PubMed ID: 38426210 [TBL] [Abstract][Full Text] [Related]
15. Reduced plasma angiotensin II levels are reversed by hydroxyurea treatment in mice with sickle cell disease. dos Santos AF; Almeida CB; Brugnerotto AF; Roversi FM; Pallis FR; Franco-Penteado CF; Lanaro C; Albuquerque DM; Leonardo FC; Costa FF; Conran N Life Sci; 2014 Nov; 117(1):7-12. PubMed ID: 25219880 [TBL] [Abstract][Full Text] [Related]
16. Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1). Youssry I; Makar S; Fawzy R; Wilson M; AbdAllah G; Fathy E; Sawires H Pediatr Nephrol; 2015 Dec; 30(12):2163-8. PubMed ID: 26238275 [TBL] [Abstract][Full Text] [Related]
17. Renal function in adult Jamaicans with homozygous sickle cell disease. Asnani MR; Reid ME Hematology; 2015 Aug; 20(7):422-8. PubMed ID: 25431929 [TBL] [Abstract][Full Text] [Related]
18. Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease. Bergmann S; Zheng D; Barredo J; Abboud MR; Jaffa AA J Pediatr Hematol Oncol; 2006 Mar; 28(3):147-53. PubMed ID: 16679937 [TBL] [Abstract][Full Text] [Related]
19. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC. Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090 [TBL] [Abstract][Full Text] [Related]
20. Changes in urine albumin to creatinine ratio with the initiation of hydroxyurea therapy among children and adolescents with sickle cell disease. Tehseen S; Joiner CH; Lane PA; Yee ME Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28612449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]